To the top

Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM

Tell a friend about this page
Print version

Katakam and co-workers ha… - University of Gothenburg, Sweden Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Katakam and co-workers have not shown SSRIs to be harmful and ineffective and should stop claiming that they have.

Journal article
Authors Fredrik Hieronymus
Alexander Lisinski
Jakob Näslund
Elias Eriksson
Published in Acta neuropsychiatrica
Volume 30
Issue 5
Pages 266-274
ISSN 1601-5215
Publication year 2018
Published at Institute of Neuroscience and Physiology, Department of Pharmacology
Pages 266-274
Language en
Links dx.doi.org/10.1017/neu.2018.15
www.ncbi.nlm.nih.gov/entrez/query.f...
Keywords Humans, Serotonin Uptake Inhibitors
Subject categories Pharmacology

Abstract

Funded by the Danish state to provide guidance in health-related matters, the Copenhagen Trial Unit (CTU) at Rigshospitalet may cause considerable societal harm if allowing their analyses to be influenced by bias and prejudice rather than rigor and impartiality. This is why we found it worthwhile to comment on a report from the CTU in which the authors invoked analyses marred by numerous errors and methodological mistakes to claim that selective serotonin reuptake inhibitors (SSRIs) are harmful and ineffective. The CTU group has now produced a response to our comment which is on par with their original contribution in terms of bias, misconceptions and mistakes. Our conclusion is that the reputation of the CTU would be best served by the authors asking for retraction of their SSRI paper.

Page Manager: Webmaster|Last update: 9/11/2012
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?

Denna text är utskriven från följande webbsida:
http://www.gu.se/english/research/publication/?publicationId=279295
Utskriftsdatum: 2019-08-24